<DOC>
	<DOCNO>NCT02188082</DOCNO>
	<brief_summary>Ivabradine act inhibit ionic If current modulates pacemaker activity sinoatrial node cell . The aim present study evaluate efficacy safety IvabRadine hemisulfate Sustained-release Tablets versus placebo patient moderate severe chronic systolic heart failure .</brief_summary>
	<brief_title>Clinical Trial Systolic Heart Failure Treatment IvabRadine Hemisulfate Sustained-release Tablets （FIRST）</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure , Systolic</mesh_term>
	<criteria>age 18 75 year , male female Willing provide write informed consent NYHA Class II , III , IV for≥4 week , stable clinical condition ≥4 week Optimized unchanged chronic heart failure medication dosages for≥4 week Sinus rhythm rest heart rate≥70 b.p.m . Leftventricular systolic dysfunction , ejection fraction≥40 % document within previous 1 month Unstable cardiovascular condition ( example , hospital admission worsen heart failure ) Recent ( ＜2 month ) myocardial infarction recent schedule coronary revascularization Stroke transient cerebral ischaemia within previous 4 week Severe primary valvular disease Scheduled surgery valvular heart disease Active myocarditis Congenital heart diseases peripartum cardiomyopathy hyperthyroid heart disease On list cardiac transplantation Cardiac resynchronization therapy start within previous 6 month Pacemaker atrial ventricular pacing ( except biventricular pace ) ˃40 % time , stimulation threshold atrial ventricular level˃60 b.p.m . Permanent atrial fibrillation flutter Sick sinus syndrome , sinoatrial block , second third degree atrioventricular block History symptomatic sustain ( ≥30 ) ventricular arrhythmia unless cardioverter/defibrillator implant Cardioverter/defibrillator shock within previous 6 month Family history congenital long QT syndrome treat select QTprolonging product ( except amiodarone ) Contraindication intolerance ivabradine lactulose Severe uncontrolled hypertension ( SBP≥180 mmHg DBP≥110 mmHg ) know anaemia ( Hb＜100 g/L ) Known moderate severe liver disease ( ALT/AST˃3ULN ) , know severe renal disease ( Cr˃2ULN ) Pregnant lactate woman woman plan become pregnant Use investigational drug within 30 day enrollment Has history psychological illness/condition interfere ability understand complete requirement study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>